The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis

por Kobelt, Dennis, Perez-Hernandez, Daniel, Fleuter, Claudia, Dahlmann, Mathias, Zincke, Fabian, Smith, Janice, Migotti, Rebekka, Popp, Oliver, Burock, Susen, Walther, Wolfgang, Dittmar, Gunnar, Mertins, Philipp, Stein, Ulrike
Publicado 2021